TY - JOUR
T1 - Loss of Retrograde Endocannabinoid Signaling and Reduced Adult Neurogenesis in Diacylglycerol Lipase Knock-out Mice
AU - Gao, Ying
AU - Vasilyev, Dmitry V.
AU - Goncalves, Maria Beatriz
AU - Howell, Fiona V.
AU - Hobbs, Carl
AU - Reisenberg, Melina
AU - Shen, Ru
AU - Zhang, Mei-Yi
AU - Strassle, Brian W.
AU - Lu, Peimin
AU - Mark, Lilly
AU - Piesla, Michael J.
AU - Deng, Kangwen
AU - Kouranova, Evguenia V.
AU - Ring, Robert H.
AU - Whiteside, Garth T.
AU - Bates, Brian
AU - Walsh, Frank S.
AU - Williams, Gareth
AU - Pangalos, Menelas N.
AU - Samad, Tarek A.
AU - Doherty, Patrick
PY - 2010/2/10
Y1 - 2010/2/10
N2 - Endocannabinoids (eCBs) function as retrograde signaling molecules at synapses throughout the brain, regulate axonal growth and guidance during development, and drive adult neurogenesis. There remains a lack of genetic evidence as to the identity of the enzyme(s) responsible for the synthesis of eCBs in the brain. Diacylglycerol lipase-alpha (DAGL alpha) and -beta (DAGL alpha) synthesize 2-arachidonoyl-glycerol (2-AG), the most abundant eCB in the brain. However, their respective contribution to this and to eCB signaling has not been tested. In the present study, we show similar to 80% reductions in 2-AG levels in the brain and spinal cord in DAGL alpha(-/-) mice and a 50% reduction in the brain in DAGL beta(-/-) mice. In contrast, DAGL beta plays a more important role than DAGL alpha in regulating 2-AG levels in the liver, with a 90% reduction seen in DAGL beta(-/-) mice. Levels of arachidonic acid decrease in parallel with 2-AG, suggesting that DAGL activity controls the steady-state levels of both lipids. In the hippocampus, the postsynaptic release of an eCB results in the transient suppression of GABA-mediated transmission at inhibitory synapses; we now show that this form of synaptic plasticity is completely lost in DAGL alpha(-/-) animals and relatively unaffected in DAGL beta(-/-) animals. Finally, we show that the control of adult neurogenesis in the hippocampus and subventricular zone is compromised in the DAGL alpha(-/-) and/or DAGL beta(-/-) mice. These findings provide the first evidence that DAGL alpha is the major biosynthetic enzyme for 2-AG in the nervous system and reveal an essential role for this enzyme in regulating retrograde synaptic plasticity and adult neurogenesis.
AB - Endocannabinoids (eCBs) function as retrograde signaling molecules at synapses throughout the brain, regulate axonal growth and guidance during development, and drive adult neurogenesis. There remains a lack of genetic evidence as to the identity of the enzyme(s) responsible for the synthesis of eCBs in the brain. Diacylglycerol lipase-alpha (DAGL alpha) and -beta (DAGL alpha) synthesize 2-arachidonoyl-glycerol (2-AG), the most abundant eCB in the brain. However, their respective contribution to this and to eCB signaling has not been tested. In the present study, we show similar to 80% reductions in 2-AG levels in the brain and spinal cord in DAGL alpha(-/-) mice and a 50% reduction in the brain in DAGL beta(-/-) mice. In contrast, DAGL beta plays a more important role than DAGL alpha in regulating 2-AG levels in the liver, with a 90% reduction seen in DAGL beta(-/-) mice. Levels of arachidonic acid decrease in parallel with 2-AG, suggesting that DAGL activity controls the steady-state levels of both lipids. In the hippocampus, the postsynaptic release of an eCB results in the transient suppression of GABA-mediated transmission at inhibitory synapses; we now show that this form of synaptic plasticity is completely lost in DAGL alpha(-/-) animals and relatively unaffected in DAGL beta(-/-) animals. Finally, we show that the control of adult neurogenesis in the hippocampus and subventricular zone is compromised in the DAGL alpha(-/-) and/or DAGL beta(-/-) mice. These findings provide the first evidence that DAGL alpha is the major biosynthetic enzyme for 2-AG in the nervous system and reveal an essential role for this enzyme in regulating retrograde synaptic plasticity and adult neurogenesis.
U2 - 10.1523/JNEUROSCI.5693-09.2010
DO - 10.1523/JNEUROSCI.5693-09.2010
M3 - Article
SN - 1529-2401
VL - 30
SP - 2017
EP - 2024
JO - Journal of Neuroscience
JF - Journal of Neuroscience
IS - 6
ER -